Posted 9/19/2023, 9:13:00 PM
Eli Lilly Sues U.S. Pharmacies for Selling Unapproved Versions of Diabetes Drug as Weight Loss Treatment
- Eli Lilly sues 10 U.S. pharmacies for selling bogus versions of diabetes drug Mounjaro as weight loss treatment
- Lawsuits filed against medical spas, wellness centers, and compounding pharmacies in multiple states
- Accuses defendants of trademark infringement and violating consumer protection laws
- Seeking injunctions barring sales of unapproved tirzepatide and unspecified damages
- Comes after Novo Nordisk sued over sales of fake versions of rival obesity drug Wegovy